Medical Devices: Page
-
J&J closes acquisition of heart pump maker Abiomed
The $16.6 billion purchase was the largest medtech transaction of 2022.
By Elise Reuter • Dec. 22, 2022 -
Philips’ studies argue recalled DreamStation CPAP machines unlikely to harm patients’ health
In a briefing on testing of the machines, Philips said exposure to degraded foam used to soundproof the devices is unlikely to harm patients.
By Elise Reuter • Dec. 21, 2022 -
Explore the Trendline➔
Sarah Silbiger via Getty Images
TrendlineTop 5 stories from MedTech Dive
From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
Diagnostic testing reform missing from Congress’ year-end spending bill
A provision that would have brought in-vitro diagnostic tests and lab-developed tests under one regulatory framework was not included in the omnibus spending bill.
By Elise Reuter • Dec. 21, 2022 -
Olympus agrees to $80M takeover of artificial intelligence endoscopy startup Odin Vision
The acquisition gives Olympus control of cloud-based AI systems to help detect and characterize cancerous and precancerous tissues during colonoscopies and gastroscopies.
By Nick Paul Taylor • Dec. 21, 2022 -
As diabetes technology advances, blood glucose control declines: study
Mexican-American and non-Hispanic Black adults saw the greatest drop as the proportion of patients with glycemic control fell from 29.2% between 1988 and 1994 to 27.5% between 2013 and 2020.
By Nick Paul Taylor • Dec. 21, 2022 -
Medtronic starts US robotic surgery trial in push to challenge Intuitive
Medtronic delayed the Hugo program to make changes in light of surgeon feedback, but now plans to evaluate the use of the surgical robot in urologic procedures, facing off against competitor Intuitive.
By Nick Paul Taylor • Dec. 20, 2022 -
MDR costs are driving manufacturers to pull products from European market: report
The report adds to evidence that makers of products used for pediatric patients and rare diseases have been particularly hard hit.
By Nick Paul Taylor • Dec. 20, 2022 -
Fraud risk increased among Medicare DME suppliers who enrolled under pandemic waivers: GAO
Of 208 providers that had their Medicare enrollment revoked between 2020 and 2022, 83% were durable medical equipment suppliers, according to a report from the Government Accountability Office.
By Elise Reuter • Dec. 19, 2022 -
J&J subsidiaries accuse former Auris employees of stealing robotic surgery trade secrets
The lawsuit claims former Auris employees engaged in “shameless, systematic and ongoing misappropriation of trade secrets.”
By Nick Paul Taylor • Dec. 19, 2022 -
Click wins FDA breakthrough designation for prescription digital migraine therapy
The designation would give Click Therapeutics expedited review of its preventive treatment for episodic migraine in adults.
By Nick Paul Taylor • Dec. 19, 2022 -
Gates, Bezos invest in Synchron’s brain computer interface
A $75 million investment will accelerate the development of a drill-free implant to help patients with upper-limb paralysis.
By Peter Green • Dec. 16, 2022 -
Siemens, GE Healthcare are interested in Medtronic spinoff units: Bloomberg
Medtronic said in October it plans to divest its patient monitoring and respiratory interventions businesses.
By Elise Reuter • Dec. 15, 2022 -
Masimo links passive health monitors to home stereos amid legal row with Apple
The move integrates the consumer audio brands Masimo bought in April with its wearable health monitors.
By Peter Green • Dec. 15, 2022 -
Dexcom’s Jake Leach discusses preparations for G7 launch next year
The diabetes tech company is in conversations with payers and is opening a new manufacturing plant ahead of the planned launch of its newest CGM, the COO said.
By Elise Reuter • Dec. 15, 2022 -
J&J leads $85M investment in HistoSonics ahead of liver cancer device authorization
HistoSonics is developing a device that delivers focused ultrasound to destroy and liquefy unwanted tissue and tumors without the need for surgical incisions.
By Nick Paul Taylor • Dec. 14, 2022 -
Tandem agrees to buy AMF, challenging Insulet for insulin pump patch market
The deal will give Tandem control of Sigi, a reusable, rechargeable patch pump that is designed to be smaller and lighter than existing devices.
By Nick Paul Taylor • Dec. 14, 2022 -
Deep Dive
Apple locked in court battles with small medtech firms over allegations of stolen technology
AliveCor and Masimo are looking to bar Apple from selling watches that use technology the firms claim they invented.
By Elise Reuter , Nick Paul Taylor • Updated Dec. 13, 2022 -
Boston Scientific pays $523M for control of Chinese device maker Acotec
The acquisition will give Boston greater access to the Chinese market, which the U.S. firm expects will account for 25% of the global medtech demand by 2030.
By Peter Green • Dec. 12, 2022 -
Ypsomed seeks new partner for US insulin pump launch as Lilly quits deal
The companies planned to launch a customized version of the YpsoPump that used pre-filled insulin cartridges for Lilly’s rapid-acting insulins.
By Nick Paul Taylor • Dec. 12, 2022 -
EU Health Commissioner proposes MDR delay to prevent medical device shortages
Plans to delay MDR certification to 2027 for high-risk devices and 2028 for others may still not be enough to stave off shortages.
By Nick Paul Taylor • Updated Dec. 23, 2022 -
Investors hand Vaxxas $23M to support trial of needle-free COVID-19 vaccine
With support from the Gates Foundation, the needle-free technology could get more people vaccinated and avoid cold-chain issues.
By Nick Paul Taylor • Dec. 12, 2022 -
Q&A
Friday Q&A: GE Healthcare’s Arduini, Zodl talk about spinoff, M&A, margins, Jack Welch
The CEO and CFO of the company spoke with MedTech Dive just weeks before the healthcare business formally separates from General Electric.
By Peter Green • Dec. 9, 2022 -
Chinese market recovery could spur international medtech growth in 2023: Goldman
A gradual return to normal and a new government quota could ramp up medical device sales in China later in 2023, the analysts wrote.
By Nick Paul Taylor • Dec. 9, 2022 -
Cochlear’s $120M purchase of hearing-implant maker stirs European scrutiny
The European Commission said the merger “threatens to significantly affect competition in the market for cochlear implants and bone conduction solutions.”
By Nick Paul Taylor • Dec. 9, 2022 -
Dexcom’s G7 glucose monitor wins awaited FDA clearance
The new Dexcom monitor is expected to generate significant patient demand, as it has been cleared by the FDA for patients with Type 1 and Type 2 diabetes, as well as gestational diabetes.
By Elise Reuter • Dec. 8, 2022